You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-712-ESGO Real-world prevalence of microsatellite instability testing and related status in patients with recurrent or advanced endometrial cancer initiating first line of therapy in Europe

Article metrics

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-712-ESGO Real-world prevalence of microsatellite instability testing and related status in patients with recurrent or advanced endometrial cancer initiating first line of therapy in Europe
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to September 2024

AbstractFullPdf
Oct 2022503
Nov 20224008
Dec 202245013
Jan 20232907
Feb 20231204
Mar 20231703
Apr 20233407
May 20231101
Jun 20235209
Jul 202327011
Aug 20231707
Sep 20231206
Oct 20231305
Nov 20231404
Dec 20231605
Jan 2024403
Feb 20242602
Mar 20241408
Apr 20242209
May 20241004
Jun 2024802
Jul 20242508
Aug 2024705
Sep 20241300
Total4730134